Themis Medicare Ltd Falls 6.23%: Mixed Signals and Fundamental Challenges Define the Week
2026-11-21 17:06:29Key Events This Week 16 Nov: Stabilised financial trend reported amid mixed quarterly results 17 Nov: Technical momentum shifts amid market pressure; stock drops 6.37% 18 Nov: Quality grade downgraded to below average; Mojo Grade cut to Strong Sell 19 Nov: Mild daily price recovery to ₹97.36 (+1.27%) 20 Nov: Stock closes at ₹95.18, down 2.24% on the day Week Open<div class="stat-va...
Read More
Themis Medicare Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-11-18 08:02:08Themis Medicare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a modest 1.43% gain on 18 Nov 2026, the stock’s technical indicators present a complex picture, with bearish signals on weekly MACD and Bollinger Bands contrasting with mildly bullish monthly readings and daily moving averages. This article analyses these technical parameters in detail, alongside the stock’s recent price performance and relative returns compared to the Sensex.
Read More
Themis Medicare Ltd Quality Grade Downgrade Highlights Fundamental Weaknesses
2026-11-18 08:00:17Themis Medicare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently seen its quality grade downgraded from average to below average, accompanied by a Mojo Score decline to 23.0 and a Strong Sell rating. This article delves into the key financial and operational metrics that have influenced this downgrade, analysing the deterioration in profitability, leverage, and growth consistency that investors should carefully consider.
Read More
Themis Medicare Ltd Technical Momentum Shifts Amid Market Pressure
2026-11-17 08:01:57Themis Medicare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite this, the stock’s recent price action and technical indicators present a complex picture, reflecting both bearish pressures and emerging positive signals amid a challenging market environment.
Read More
Themis Medicare Ltd Reports Stabilised Financial Trend Amid Mixed Quarterly Performance
2026-11-16 13:00:26Themis Medicare Ltd reported a flat financial performance for the quarter ended September 2026, marking a notable improvement from the previous negative trend. While profit before tax (PBT) and profit after tax (PAT) have shown robust growth compared to the last four quarters, the company continues to grapple with a high proportion of non-operating income impacting core profitability. This article analyses the recent quarterly results in the context of historical trends and market performance.
Read More
Themis Medicare Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-11-16 08:01:46Themis Medicare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, reflecting uncertainty in near-term price direction.
Read MoreThemis Medicare Gains 7.13%: 4 Key Factors Driving This Week’s Mixed Momentum
2026-11-07 17:06:27Key Events This Week 2 Nov: Technical momentum shifts amid mixed market signals 3 Nov: Mildly bullish technical stance emerges with renewed price gains 6 Nov: Downgrade to Strong Sell amid weak financials and bearish technicals 6 Nov: Technical momentum shifts back to sideways with bearish undertones Week OpenRs.95.00 Week ...
Read More
Themis Medicare Ltd is Rated Sell by MarketsMOJO
2026-10-31 10:10:24Themis Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 October 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.
Read More
Themis Medicare Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-10-28 08:02:29Themis Medicare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite this positive directional change, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, reflecting a cautious outlook for investors navigating the current market environment.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
16-Nov-2026 | Source : BSENewspaper Publication of Un-audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30.09.2026
Announcement under Regulation 30 (LODR)-Investor Presentation
15-Nov-2026 | Source : BSEPlease refer to the attachment
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.11.2026
14-Nov-2026 | Source : BSEKindly refer to the Outcome of the Board Meeting held on 14.11.2026
Corporate Actions
No Upcoming Board Meetings
Themis Medicare Ltd has declared 50% dividend, ex-date: 23 Sep 26
Themis Medicare Ltd has announced 1:10 stock split, ex-date: 10 Oct 23
No Bonus history available
No Rights history available